Mastodawn

Jorge Caballero, MD Mar 1, 2023

❌ Eli Lilly lowers the cost of insulin in U.S.
✅ Eli Lilly reluctantly complies with Democratic law that caps out-of-pocket cost of insulin

Eli Lilly is a global corporation that actively participates and defends its role in the insulin oligopoly. Eli Lilly isn't capping the cost of jack squat. Eli Lilly was forced to stop exploiting patients－ that's the story, and the headline. Do better, editors.

#insulin

Show thread

Halcek

@DataDrivenMD If the democrats could achieve capping the out of pocket price for insulin, they could also reduce the out of pocket price to zero, which’s where it should be for such a life-saving drug. Incrementalism is still costly, because it’s pricing a lot of people out altogether. Making something just a little more affordable for people who could with some difficulty still afford it before, does exactly nothing for people who urgently need it, yet couldn’t afford the medicine.